Kurucay Mustafa, Kloth Christopher, Kaufmann Sascha, Nikolaou Konstantin, Bösmüller Hans, Horger Marius, Thaiss Wolfgang M
Department of Radiology, Diagnostic and Interventional Radiology, Eberhard Karls University, Hoppe-Seyler-Str. 3, D-72076, Tuebingen, Germany.
Department of Pathology, Eberhard Karls University, Liebermeisterstraße 8, D-72076, Tuebingen, Germany.
Cancer Imaging. 2017 Jun 28;17(1):18. doi: 10.1186/s40644-017-0121-9.
MRI and perfusion-CT (PCT) are both useful imaging techniques for detection and characterization of liver lesions. The aim of this study was to compare the diagnostic accuracy of imaging parameters derived from PCT and gadoxetic acid-enhanced MRI in patients with hepatocellular carcinoma (HCC).
36 patients with liver cirrhosis and a total of 67 lesions referred to our hospital for multi-parametric diagnosis of HCC-suspected liver lesions in the setting of liver cirrhosis were prospectively enrolled and underwent PCT and MRI. HCC diagnosis was confirmed either by histology (n = 60) or interval growth (n = 7). For PCT, mean/max blood flow (BF), blood volume (BV), k-trans, arterial liver perfusion (ALP), portal venous perfusion (PVP) and hepatic perfusion index (HPI) were quantified. Two readers identified the lesions based on single maps each being blinded to the number of lesions. MRI-protocol included fat-suppressed T1w-VIBE sequences obtained before, 2, 5, 10 and 20 min after the injection of gadoxetic acid as well as non-enhanced coronal HASTE, axial T1w-VIBE, fat-suppressed T2w-TSE and DWI. Quantitative analysis was performed using enhancement ratios between tumor and liver parenchyma for post-contrast in the hepatobiliary phase (RIR), arterial (ER) and late-venous (ER) phases as well as signal intensity ratios (liver/parenchyma) on T1w (RIR) and T2w (RIR).
In PCT analysis, all lesions exhibited high BF values (63-250 mL/100 g tissue) and were visible on HPI maps with high degrees of arterial blood supply of (HPI > 96%). In MRI, RIR was negative in 8/67. 12/67 HCCs were missed on DWI. 46/67 HCCs showed wash-in and 47/67 HCC showed wash-out of contrast agent. 6/67 HCCs were missed on T1w and 11/67 were missed on T2w-sequences when analyzed separately, while analysis of multiparametric MRI combining typical enhancement pattern, visibility on hepatobiliary phase and T1w-images the same number of lesions as PCT irrespective of their size (1-19 cm) were detected. Quantification of early enhancement by ER or ER did not improve detection rates.
Perfusion-CT and gadoxetic acid-enhanced MRI were comparable in detecting HCC lesions. For PCT a mean HPI > 96% proved to be a very robust parameter for detection and characterization of HCC.
MRI和灌注CT(PCT)都是用于检测和鉴别肝脏病变的有用成像技术。本研究的目的是比较PCT和钆塞酸增强MRI得出的成像参数对肝细胞癌(HCC)患者的诊断准确性。
前瞻性纳入36例肝硬化患者,共67个病变,这些患者因肝硬化背景下疑似HCC的肝脏病变前来我院进行多参数诊断,并接受了PCT和MRI检查。HCC诊断通过组织学(n = 60)或间隔期生长(n = 7)得以证实。对于PCT,定量分析平均/最大血流(BF)、血容量(BV)、ktrans、肝动脉灌注(ALP)、门静脉灌注(PVP)和肝灌注指数(HPI)。两位阅片者分别根据单一图像识别病变,且对病变数量不知情。MRI检查方案包括注射钆塞酸前、注射后2、5、10和20分钟获取的脂肪抑制T1w-VIBE序列,以及非增强冠状位HASTE、轴位T1w-VIBE、脂肪抑制T2w-TSE和DWI序列。使用肝胆期(RIR)、动脉期(ER)和延迟静脉期(ER)肿瘤与肝实质之间的增强率以及T1w(RIR)和T2w(RIR)上的信号强度比(肝脏/实质)进行定量分析。
在PCT分析中,所有病变均表现出高BF值(63 - 250 mL/100 g组织),且在HPI图上可见,具有高度的动脉血供(HPI > 96%)。在MRI检查中,67个病变中有8个RIR为阴性。12个HCC在DWI上漏诊。67个HCC中有46个表现为造影剂快进,47个表现为造影剂快出。单独分析时,67个HCC中有6个在T1w上漏诊,11个在T2w序列上漏诊,而综合典型增强模式、肝胆期可见性和T1w图像的多参数MRI分析,无论病变大小(1 - 19 cm),检测到的病变数量与PCT相同。通过ER或ER对早期增强进行定量分析并未提高检测率。
灌注CT和钆塞酸增强MRI在检测HCC病变方面具有可比性。对于PCT,平均HPI > 96%被证明是检测和鉴别HCC的一个非常可靠的参数。